1. Reliability and feasibility of home-based dried blood spot in therapeutic drug monitoring: a systematic review and meta-analysis

   • Xu Xiaoyong
   • Ge Xilin
   • Li Zhiping

   Review 05 December 2022 Pages: 183 - 193

   

2. Linezolid pharmacokinetics: a systematic review for the best clinical practice

   • Shima Heidari
   • Hossein Khalili

   Review 24 December 2022 Pages: 195 - 206

3. Duplicate prescriptions in the emergency department: a retrospective cohort study

   • Johannes Heck
   • Benjamin Krichevsky
   • Olaf Krause

   Research Open access 08 December 2022 Pages: 207 - 217

   

4. Inhalation therapies in COPD — adverse drug reactions impact on emergency department presentations

   • Ingmar Bergs
   • Katja S. Just
   • Julia C. Stingl

   Research Open access 09 December 2022 Pages: 219 - 227

   

5. Patient involvement in pharmacovigilance: determinants and evolution of reporting from 2011 to 2020 in France

   • D. Adopo
   • P. Daynes
   • P. Maison

   Research Open access 12 December 2022 Pages: 229 - 236

   

6. Patients with bariatric surgery: Urgent need for accurate registration of the contraindication to enable safe pharmacotherapy in hospital and primary care

   • Cedric Lau
   • Ouarda Sbaa
   • Charlotte van Kesteren

   Research 13 December 2022 Pages: 237 - 242

   

7. The effect of concomitant use of proton pump inhibitors with CDK 4/6 inhibitors on survival in metastatic breast cancer

   • Dilek Çağlayan
   • Mehmet Zahid Koçak
   • Mehmet Artaç

   Research 15 December 2022 Pages: 243 - 248

   

8. Premature termination of clinical trials in Spain: reasons, characteristics, and opportunities to improve

   • Francesca Filippi-Arriaga
   • Ricardo Javier Boy
   • Alexis Rodríguez Gallego

   Research 16 December 2022 Pages: 249 - 256

   

9. Abuse, dependence and withdrawal associated with fentanyl and the role of its (designated) route of administration: an analysis of spontaneous reports from Europe

   • Kathrin Jobski
   • Carsten Bantel
   • Falk Hoffmann

   Research Open access 16 December 2022 Pages: 257 - 267

   

10. Imprecision in adverse event reports following immunization against HPV in Japan and COVID-19 in the USA, UK, and Japan—and the effects of vaccine hesitancy and government policy

    • Yasuko Inokuma
    • Robert Kneller

    Research 17 December 2022 Pages: 269 - 278

    

11. Effectiveness and safety of vonoprazan-based regimens compared with those of proton pump inhibitor (PPI)–based regimens as first-line agents for Helicobacter pylori: a meta-analysis of randomized clinical trials

    • Yingchao Sun
    • Lei Yue
    • Weiling Hu

    Research 17 December 2022 Pages: 279 - 288

    

12. Cost-utility analysis of a structured medication review compared to usual care in Parkinson’s disease

    • N. G. M. Oonk
    • L. D. A. Dorresteijn
    • H. Koffijberg

    Research 23 December 2022 Pages: 289 - 297

    

13. Effect of metformin as an adjuvant therapy to letrozole on estradiol and other biomarkers involved in the pathogenesis of breast cancer in overweight and obese postmenopausal women: a pilot study

    • Aya Ahmed El-attar
    • Osama Mohamed Ibrahim
    • Tarek Mohamed Mostafa

    Research Open access 23 December 2022 Pages: 299 - 309

    

14. Application of machine learning to predict tacrolimus exposure in liver and kidney transplant patients given the MeltDose formulation

    • Laure Ponthier
    • Pierre Marquet
    • Jean Baptiste Woillard

    Research 24 December 2022 Pages: 311 - 319

    

15. Why we should not recommend or offer fluvoxamine to COVID-19 patients?

    • Vladimir Trkulja

    Correspondence 23 December 2022 Pages: 321 - 322